Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1
10.1136/heartasia-2016-010728
Saved in:
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
BMJ
2022
|
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/228038 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-228038 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2280382024-04-17T08:36:00Z Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1 Ling, Lieng H Oh, Vernon MS MEDICINE 10.1136/heartasia-2016-010728 Heart Asia 8 1 28-29 2022-07-06T08:04:43Z 2022-07-06T08:04:43Z 2016-02 2022-07-06T04:32:07Z Article Ling, Lieng H, Oh, Vernon MS (2016-02). Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1. Heart Asia 8 (1) : 28-29. ScholarBank@NUS Repository. https://doi.org/10.1136/heartasia-2016-010728 17591104 https://scholarbank.nus.edu.sg/handle/10635/228038 BMJ Elements |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| description |
10.1136/heartasia-2016-010728 |
| author2 |
MEDICINE |
| author_facet |
MEDICINE Ling, Lieng H Oh, Vernon MS |
| format |
Article |
| author |
Ling, Lieng H Oh, Vernon MS |
| spellingShingle |
Ling, Lieng H Oh, Vernon MS Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1 |
| author_sort |
Ling, Lieng H |
| title |
Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1 |
| title_short |
Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1 |
| title_full |
Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1 |
| title_fullStr |
Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1 |
| title_full_unstemmed |
Nebivolol as a first-line antihypertensive: a justifiable proposal?: Table 1 |
| title_sort |
nebivolol as a first-line antihypertensive: a justifiable proposal?: table 1 |
| publisher |
BMJ |
| publishDate |
2022 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/228038 |
| _version_ |
1800915447403511808 |